irritable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patient (1) People aged 18-80 years old; (2) The diagnosis of IBS meets the Rome IV diagnostic criteria; (3) the course of disease should be at least 6 months; (4) Total score of IBS symptom severity in baseline period > 75 points ; (5) There was no abnormality in routine occult blood within one month; (6) Participate in the experiment voluntarily and sign the informed consent. Heathy people : (1) Gender is not limited, age = 18 years old =80 years old; (2) They reported no abdominal pain and diarrhea for more than three days within 6 months and did not meet the diagnostic criteria for irritable bowel syndrome; (3) junior high school degree or above; (4) had not taken any antidiarrheal medication for at least 4 weeks before entering the study; (5) Voluntarily participate in the study of this project, signed the informed consent by myself, and do not participate in other ongoing studies;)
Exclusion criteria
Exclusion criteria: 1. Organic intestinal lesions (including but not limited to patients with ulcerative colitis and colorectal cancer) were found by previous colonoscopy, barium fluoroscopy and abdominal ultrasound; 2. Patients with one or more of the following warning symptoms: stool blood, fecal occult blood test positive, anemia, abdominal mass, ascites, fever, weight loss; 3. Patients with serious diseases of cardiovascular system, endocrine system and rheumatic immune system affecting the diagnosis of disease; 4. Patients with unconsciousness, unable to express subjective discomfort symptoms, and definite diagnosis of serious mental disorders; 5, severe depression patients (SDS total score > 56); 6. Pregnant or lactating women; 7. Patients who have received acupuncture treatment for IBS in the last three months; (1) Abdominal pain accompanied by fecal changes in the past week; (2) Patients with serious primary diseases (cardiovascular, lung, liver and other systems), serious wasting diseases (malignant tumors, etc.), and systemic diseases (pain, fever, surgery, etc.); (3) A history of irritable bowel syndrome; (4) women who are pregnant, preparing for pregnancy or breastfeeding; (5) Patients with unconsciousness, difficulty in expressing subjective discomfort symptoms, and patients with mental illness; (6) Those who are participating in other clinical research trials; Note: Subjects meeting any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mechanical pain threshold;tenderness threshold;impedance value;IBS severity table; | — |
Secondary
| Measure | Time frame |
|---|---|
| The Adequate Relief of IBS Symptoms Scale;Table of defecation times;Stool Trait Table; | — |
Countries
China
Contacts
Chengdu University of TCM